Budapest, Hungary

Andras Boza


Average Co-Inventor Count = 12.5

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andras Boza – Innovator from Budapest

Introduction

Andras Boza is a prominent inventor based in Budapest, Hungary. With a focus on pharmaceutical innovations, he has made significant contributions to the field, particularly in the development of antithrombotic agents. His work not only showcases his inventive spirit but also his dedication to improving healthcare outcomes.

Latest Patents

Andras holds two patents related to the preparation of important pharmaceutical compounds. The first patent, entitled "Process for the preparation of a rivaroxaban and intermediates formed in said process," involves a unique method of synthesizing rivaroxaban, a key medication used for preventing blood clots. The second patent, titled "Pharmaceutical intermediates and process for the preparation thereof," details a process for producing dabigatran etexilate, another critical anticoagulant. These innovations demonstrate his expertise in the realm of medicinal chemistry.

Career Highlights

Andras Boza works at Egis Gyógyszergyár Nyilvánosan Mukodo Részvénytársaság, a leading pharmaceutical company in Hungary. His contributions to the company underscore his role as a vital asset in driving advancements in drug development. His inventive work equips the medical community with more effective treatments and therapeutic options.

Collaborations

Throughout his career, Andras has collaborated with notable colleagues, including Balazs Volk and Gyorgy Ruzsics. These partnerships not only enhance the research environment but also facilitate the exchange of ideas essential for groundbreaking innovations in medicine.

Conclusion

Andras Boza's dedication to research and innovation in pharmaceuticals exemplifies the crucial role inventors play in the healthcare industry. His patents reflect an ongoing commitment to developing effective treatments that benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…